Summary

North America Pharmaceuticals Market Summary, Competitive Analysis and Forecast to 2026

Summary

Pharmaceuticals in North America industry profile provides top-line qualitative and quantitative summary information including: market size (value 2016-21, and forecast to 2026). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
- The North American pharmaceuticals market had total revenues of $446.2 billion in 2021, representing a compound annual growth rate (CAGR) of 4.4% between 2016 and 2021.
- The US pharmaceuticals market is the largest in the North American region, accounting for 89.0% of the market. Comparatively, the Canadian and Mexican markets hold 5.8% and 5.2%, respectively.
- The COVID-19 pandemic has had a significant impact on industries around the world, with many businesses experiencing disruption to productivity and revenues as a result of nationwide lockdowns, social distancing measures, and self-isolation requirements.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the pharmaceuticals market in North America
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in North America
- Leading company profiles reveal details of key pharmaceuticals market players’ global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the North America pharmaceuticals market with five year forecasts

Reasons to Buy

- What was the size of the North America pharmaceuticals market by value in 2021?
- What will be the size of the North America pharmaceuticals market in 2026?
- What factors are affecting the strength of competition in the North America pharmaceuticals market?
- How has the market performed over the last five years?
-

ページTOPに戻る

Table of Contents

Table of Contents
1 Executive Summary
1.1. Market value
1.2. Market value forecast
1.3. Geography segmentation
1.4. Market share
1.5. Market rivalry
1.6. Competitive Landscape
2 Market Overview
2.1. Market definition
2.2. Market analysis
3 Market Data
3.1. Market value
4 Market Segmentation
4.1. Geography segmentation
5 Market Outlook
5.1. Market value forecast
6 Five Forces Analysis
6.1. Summary
6.2. Buyer power
6.3. Supplier power
6.4. New entrants
6.5. Threat of substitutes
6.6. Degree of rivalry
7 Competitive Landscape
7.1. Market share
7.2. Who are the leading players?
7.3. What strategies do leading players follow?
7.4. What has been the rationale behind recent M&A activity?
7.5. How does government regulation impact leading players?
7.6. What impact is the COVID-19 pandemic having on the market?
8 Company Profiles
8.1. Johnson & Johnson
8.2. Pfizer Inc.
8.3. AstraZeneca PLC
8.4. Merck & Co., Inc.
9 Macroeconomic Indicators
9.1. Country data
10 Appendix
10.1. Methodology
10.2. Industry associations
10.3. Related MarketLine research
10.4. About MarketLine